points by rbehrends 1 day ago | 0 comments
The major counterpoint here is commoditization; you may have the market growing and models becoming cheaper at the same time. And we don't even have to look to Chinese models for that, as OpenAI has been adjusting its pricing already. For profitability, Anthropic still seems to be pretty dependent on its current price levels.
That said, I'm also somewhat skeptical that there is even much room for growth left unless somebody finds a new, important, and token-hungry use case.
[–] superchicken099 1 day ago
[–] rhdunn 1 day ago
They are also (like other models we know about) experimenting with the architecture. [2]
[1] https://arxiv.org/abs/2501.12948
[2] https://sebastianraschka.com/blog/2026/kimi-k3-architecture-...
[–] famouswaffles 1 day ago
[–] rbehrends 1 day ago
[1] I don't, I think China is primarily limited by compute and will be at least for the next couple of years, probably longer.
[–] qlte 1 day ago
If Anthropic manages to start producing new pharmaceuticals with their internal models or something that thesis could make sense but not if 90% of their revenue comes from enterprise API sales which would necessarily have to be accessible to the public. Which are then inevitably fast followed by Chinese models 3 months later.
[–] SkiFire13 1 day ago